The framework has shifted from accumulation to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 6.6% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 18%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (5 analysts) rates it none, with a mean price target of $27. Insiders have been net buyers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
MasterCraft Boat Holdings Inc
MCFT · NASDAQ · USD · Market cap $605M · 700 employees
MasterCraft Boat Holdings, Inc., through its subsidiaries, designs, manufactures, and markets recreational powerboats.
Not yet scoredPrice as of 5 Nov 2026Daily close, not a live quote
Screened 2026-11-05 · the tape above runs as of 16:01 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price20.78 USD at the 5 Nov 2026 close
- Our value readUndervalued vs our fair value, as of 5 Nov 2026
- Our regime readMarkup, as of 5 Nov 2026
- Ethical screenNot yet scored
- OptionsOpen interest leans heavily to calls (put/call 0.02)
- Last reviewed5 Nov 2026 (1 days ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
Our fair-value range: $30.00 to $44.50, base estimate $30.00 (screen dated 2026-11-05).
- Trend Markup
- Insiders insiders bought, latest filing 2026-09-18
- Positioning no disclosures inside 60 days, left as found
- Options put/call open interest 0.02, read 2026-11-05
- Ethical screen not yet scored
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its markup label.
MasterCraft Boat Holdings Inc holds its Markup at $20.78. Consolidating, no directional conviction, held for 16 days.
| Phase | Markup |
| Quantitative state | Consolidating, no directional conviction, held for 16 days |
| Price at the screen | $20.78 |
| Valuation | 29.37 trailing · 9.96 forward price to earnings |
| Values screen | Not scored · score 70.0 |
| Beta | 1.05 |
Five Screens, Shown in Full
This security has not been fully scored against the values screen yet.
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | Excluded | Below 33% | Interest-bearing debt is of its assets, above the one-third ceiling the screen allows. | Fail |
| Interest-bearing cash | 19.43% | Below 33% | Cash held in interest-bearing accounts and securities is 19.4% of assets, under the one-third limit. | Pass |
| Receivables | 12.70% | Below 49% | Money owed to the company is 12.7% of assets, under the 49% limit. | Pass |
| Revenue purity | 1.22% | Below 5% | Only 1.2% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadThe Read, in Plain English
MasterCraft Boat clears the business-activity screen and the figures we can measure look clean, but its debt figure is still pending, so the verdict is not final yet.
Read as at 2026-11-05. It updates when the underlying figures move, and past reads are kept below.
What the Numbers Say It Is WorthThe Fair Value Range
Our analysis reads Undervalued vs our fair value, as of 5 Nov 2026: it trades at roughly a 26% discount to our $30.00 fair value, none competitive moat, 3.00% revenue growth.
How a fair value is estimated: discounted cash flow (DCF).
Fair value range in USD, drawn from the 2026-11-05 screen. The gold marker is the market price at the same screen. A 30.7% discount to the base estimate.
Third-party analyst targets: 5 covering, consensus Hold. The average target sits +35% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere our models see it going: fair-value estimate $30.00, with a range of $30.00 to $44.50, dated to the 2026-11-05 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsWhy it stands out
A 3%-growth business trading at just 10.0x forward earnings, with a none competitive moat. That is a 26% discount to our $30.00 fair value: the market is pricing it cautiously while the fundamentals argue otherwise. 5 analysts rate it Hold with a $28.00 average target, about 35% above the screened price.
| Forward P/E | 10.0xexpensive even after accounting for its growth |
| Trailing P/E | 29.4xa premium valuation |
| EPS, trailing | 0.67 |
| EPS, forward | 1.98 |
| Revenue growth | +3.0%slow but positive growth |
| Profit margin | 3.7%barely profitable |
| Return on equity | 5.9%a modest return on shareholder capital |
| FCF yield | 3.46% |
| Current ratio | 1.83healthy short-term liquidity |
| Beta | 1.05moves a little more than the market |
| Short interest, float | 0.05% |
| 52-week range | 17.19 - 28.44 |
| Moat | NONE |
| Market cap | $605M |
| Employees | 700 |
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeMCFT trades on NASDAQ. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 3.6% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 18%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (5 analysts) rates it none, with a mean price target of $27. Insiders have been net buyers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.1% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 18%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (5 analysts) rates it none, with a mean price target of $27. Insiders have been net buyers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 9.7% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 18%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (5 analysts) rates it none, with a mean price target of $27. Insiders have been net buyers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 18%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (5 analysts) rates it none, with a mean price target of $27. Insiders have been net buyers over the past quarter.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 1.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 18%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (5 analysts) rates it none, with a mean price target of $27. Insiders have been net buyers over the past quarter.
The framework has shifted from distribution to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 1.6% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 4% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 18%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (5 analysts) rates it none, with a mean price target of $27. Insiders have been net buyers over the past quarter.
The framework has shifted from markdown to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 21.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 4% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 18%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (5 analysts) rates it none, with a mean price target of $27. Insiders have been net buyers over the past quarter. Since the last review it its composite score rose.
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 4% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 18%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (5 analysts) rates it none, with a mean price target of $27. It reported earnings in this window, a natural checkpoint for the thesis.
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 4% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 18%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (5 analysts) rates it none, with a mean price target of $27. It reported earnings in this window, a natural checkpoint for the thesis.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
Screened names in the same industry · explore each on its own page.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-18 | Leemputte Peter G | Dir | P - Purchase | 1,265 | $24,958 |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $26.27 | -15.0% | · | $850 | -15.0% |
| 2 months | $21.52 | +3.8% | · | $1,038 | +3.8% |
| 3 months | $19.93 | +12.0% | · | $1,120 | +12.0% |
| 6 months | $19.13 | +16.7% | · | $1,167 | +16.7% |
| 1 year | $18.89 | +18.2% | · | $1,182 | +18.2% |
| 2 years | $20.73 | +7.7% | · | $1,077 | +7.7% |
| 3 years | $29.80 | -25.1% | · | $749 | -25.1% |
| 5 years | $25.89 | -13.8% | · | $863 | -13.8% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever MCFT does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.